Sernova Biotherapeutics Inc (FRA:PSH0)
0.1300
+0.0190 (17.12%)
Last updated: May 13, 2025
Sernova Biotherapeutics Statistics
Total Valuation
FRA:PSH0 has a market cap or net worth of EUR 42.19 million. The enterprise value is 41.77 million.
Market Cap | 42.19M |
Enterprise Value | 41.77M |
Important Dates
The next estimated earnings date is Wednesday, June 11, 2025.
Earnings Date | Jun 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 328.48M |
Shares Outstanding | n/a |
Shares Change (YoY) | +3.18% |
Shares Change (QoQ) | +3.15% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 315.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -3.54 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.23 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
Current Ratio | 0.10 |
Quick Ratio | 0.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -32.58 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -152.63% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 151.17% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.10M |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.73% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -38.73% |
50-Day Moving Average | 0.12 |
200-Day Moving Average | 0.15 |
Relative Strength Index (RSI) | 39.82 |
Average Volume (20 Days) | 8,196 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.57M |
Pretax Income | -18.70M |
Net Income | -18.71M |
EBITDA | -17.34M |
EBIT | -17.57M |
Earnings Per Share (EPS) | -0.06 |
Balance Sheet
The company has 802,729 in cash and 363,265 in debt, giving a net cash position of 439,464.
Cash & Cash Equivalents | 802,729 |
Total Debt | 363,265 |
Net Cash | 439,464 |
Net Cash Per Share | n/a |
Equity (Book Value) | -11.92M |
Book Value Per Share | -0.04 |
Working Capital | -12.30M |
Cash Flow
Operating Cash Flow | -12.95M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FRA:PSH0 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.18% |
Shareholder Yield | -3.18% |
Earnings Yield | -44.34% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |